CASE DISCUSSION
Nephrotic Syndrome in Children: Clues to Recognise
Presented by Dr. Baldev PrajapatiViews
2,966
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Nephrotic syndrome in children is a common pediatric kidney disorder characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia. Early recognition is crucial, as children often present with puffiness around the eyes, swelling of the face and limbs, frothy urine, and unexplained...
Case Summary
- Nephrotic syndrome in children is characterized by nephrotic-range proteinuria (over 40 mg/m2/hr, 100 mg/m2/day, or a protein/creatinine ratio > 2), hypoalbuminemia (albumin < 3 g/dL), and generalized edema. Hyperlipidemia, previously part of the definition, is no longer included. In children, the most common cause is idiopathic, with minimal change disease accounting for around 80% of cases. Secondary causes, seen in about 10% of cases, include systemic diseases like SLE, infections (hepatitis, malaria), and drug-induced nephrotic syndrome.
Speaker Profile
Dr. Baldev Prajapati
Senior Consultant Pediatrician, Akanksha Children Hospital, AhmedabadDr. Baldev Prajapati is a highly experienced pediatrician associated with Akanksha Children Hospital. With extensive clinical expertise in child healthcare, he specializes in the diagnosis and management of pediatric illnesses, growth and developmental concerns, and preventive pediatric care. Dr. Prajapati is known for his patient-friendly approach and commitment to improving child health outcomes through evidence-based treatment and parental guidance. His areas of interest include pediatric infections, nutrition, immunization, and neonatal care.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.